[The molecular-genetic background of spinal muscular atrophy. Diagnosis, prognosis and future treatment].
Schwartz
Marianne
M
H:S Rigshospitalet, Klinisk Genetisk Afdeling, København. schwartz@rh.dk
D017398:Alternative Splicing / Q000187:drug effects; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017362:Cyclic AMP Response Element-Binding Protein; D004252:DNA Mutational Analysis; D006801:Humans; D051379:Mice; D009134:Muscular Atrophy, Spinal / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000235:genetics; D016601:RNA-Binding Proteins; D055532:SMN Complex Proteins; D017422:Sequence Analysis, DNA; D014158:Transcription, Genetic / Q000187:drug effects
D000970:Antineoplastic Agents; D017362:Cyclic AMP Response Element-Binding Protein; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; D055532:SMN Complex Proteins